Caribou Biosciences Ownership | Who Owns Caribou Biosciences?
Caribou Biosciences Ownership Summary
Caribou Biosciences is owned by 59.50% institutional investors, 10.01% insiders, and 30.49% retail investors. Blackrock is the largest institutional shareholder, holding 7.78% of CRBU shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.06% of its assets in Caribou Biosciences shares.
CRBU Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Caribou Biosciences | 59.50% | 10.01% | 30.49% |
| Sector | Healthcare Stocks | 47.31% | 8.01% | 44.69% |
| Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 6.95M | 7.78% | $11.39M |
| Vanguard group | 4.54M | 5.09% | $7.45M |
| Bank of america corp /de/ | 4.16M | 4.66% | $6.83M |
| Pfm health sciences, lp | 4.08M | 4.57% | $6.70M |
| Dimensional fund advisors lp | 2.62M | 2.94% | $4.30M |
| Point72 asset management | 2.34M | 2.62% | $3.84M |
| Elmwood wealth management | 2.33M | 2.61% | $3.83M |
| Geode capital management | 1.91M | 2.13% | $3.13M |
| Kynam capital management, lp | 1.65M | 1.84% | $2.70M |
| State street | 1.62M | 1.81% | $2.65M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| 72 investment | 474.07K | 1.95% | $777.47K |
| Elmwood wealth management | 2.33M | 1.71% | $3.83M |
| Pfm health sciences, lp | 4.08M | 0.33% | $6.70M |
| Kynam capital management, lp | 1.65M | 0.21% | $2.70M |
| Bruce | 300.00K | 0.16% | $492.00K |
| Green alpha advisors | 77.37K | 0.10% | $126.89K |
| Milestone asset management | 142.31K | 0.06% | $233.39K |
| Xtx topco | 208.16K | 0.03% | $341.39K |
| Nelson capital management | 85.02K | 0.02% | $139.43K |
| Balboa wealth partners | 47.88K | 0.02% | $78.52K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bank of america corp /de/ | 4.16M | 0.00% | 3.05M |
| Renaissance | 1.48M | 0.00% | 1.48M |
| Two sigma advisers, lp | 1.04M | 0.00% | 989.30K |
| Two sigma investments, lp | 1.12M | 0.00% | 889.44K |
| Jane street group | 668.50K | 0.00% | 607.28K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avidity partners management lp | - | - | -5.79M |
| State street | 1.62M | 0.00% | -4.73M |
| Alkeon capital management | - | - | -2.74M |
| Pfm health sciences, lp | 4.08M | 0.33% | -2.40M |
| Paradigm biocapital advisors lp | - | - | -2.17M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Xtx topco | 208.16K | 0.03% | 208.16K | $341.39K |
| Mirae asset global etfs | 191.56K | 0.00% | 191.56K | $314.16K |
| Walleye capital | 162.80K | 0.00% | 162.80K | $266.99K |
| Milestone asset management | 142.31K | 0.06% | 142.31K | $233.39K |
| Thrivent financial for lutherans | 106.98K | 0.00% | 106.98K | $175.00K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -17.00 |
| Daiwa securities group | -176.00 |
| Piscataqua savings bank | -250.00 |
| Gamma investing | -262.00 |
| Lindbrook capital | -703.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 139 | -10.32% | 53,138,330 | -20.38% | 59 | 1.04% | 67 | -8.22% | 41 | -6.82% |
| Mar 31, 2024 | 155 | 6.90% | 66,737,162 | -3.26% | 75 | 1.11% | 73 | -10.98% | 44 | 33.33% |
| Dec 31, 2023 | 145 | 10.69% | 68,986,888 | -2.47% | 82 | 0.62% | 82 | -2.38% | 33 | 57.14% |
| Sep 30, 2023 | 131 | 4.80% | 70,733,765 | 61.84% | 115 | 2.26% | 84 | 31.25% | 21 | -16.00% |
| Jun 30, 2023 | 125 | -0.79% | 43,707,037 | -2.66% | 71 | 1.33% | 64 | 6.67% | 25 | -24.24% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.77M | 3.06% | - |
| iShares Russell 2000 ETF | 2.18M | 2.41% | -4.90K |
| ACATIS Datini Valueflex Fonds A | 2.00M | 2.21% | 18.45K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.23M | 1.36% | - |
| Fidelity Small Cap Index | 846.69K | 0.94% | -8.39K |
| iShares Russell 2000 Value ETF | 807.14K | 0.89% | - |
| Selectra J. Lamarck Biotech A | 800.00K | 0.88% | - |
| Candriam Global Equities Oncology | 625.00K | 0.69% | -520.00K |
| iShares Biotechnology ETF | 572.64K | 0.63% | -3.42K |
| Fidelity Extended Market Index | 494.47K | 0.55% | -4.30K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 19, 2023 | Rizvi Syed Ali-aamir | Chief Medical Officer | Sell | $35.51K |
| Oct 06, 2022 | Fischesser Ryan | VP of Finance and Controller | Sell | $107.96K |
| Aug 25, 2022 | Kanner Steven | Chief Scientific Officer | Sell | $485.22K |
| Jan 11, 2022 | Fischesser Ryan | VP of Finance and Controller | Buy | $1.53K |
| Jan 11, 2022 | Fischesser Ryan | VP of Finance and Controller | Buy | $28.02K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | - |
| 2024 Q1 | - | - |
| 2023 Q2 | - | - |
| 2023 Q1 | - | 1 |
| 2022 Q4 | - | 1 |
CRBU Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools